- Category
- Micro (2020-21)
- Udyam number
- UDYAM-JH-20-0000572

Curonest Pharmaceuticals Private Limited
About Curonest Pharmaceuticals Private Limited
Data last updated:
Curonest Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 18 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2020PTC133817.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rishi Ranjan and Manoranjan Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Bangalore, Karnataka.
As per the financials filed for FY 2024, the company reported a revenue of ₹38.1 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹80,353 (net margin 2.1%) and EBITDA of ₹1.65 Lakh (EBITDA margin 4.3%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years.
Curonest Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-20-0000572).
Company details
Recognitions & Rankings of Curonest Pharmaceuticals
Contact details
Curonest Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressF – 301 N.D. Oliva #29/2A&29/3 Begur Hobli Haralakunte Village Somsunderpalaya Hs, R Layout 1, Bangalore, Karnataka, India – 560037
- IndustryTrading, Specialty, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curonest Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curonest Pharmaceuticals Private Limited, buy the company report.
Financials of Curonest Pharmaceuticals Private Limited
FY 2024 filings availableCuronest Pharmaceuticals Private Limited reported revenue of ₹38.1 Lakh (down 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 16% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.65 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹80,353 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.3% | |||
| Net Profit Margin | 2.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Curonest Pharmaceuticals Private Limited, buy the company report.
Board of directors of Curonest Pharmaceuticals Private Limited
Curonest Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishi Ranjan Also directs: Curonest Lifestyle Private Limited | Director | 18 Apr 2020 | 6 Years 6 Months | Current |
| Manoranjan Kumar Also directs: Curonest Lifestyle Private Limited | Director | 18 Apr 2020 | 6 Years 6 Months | Current |
Peer comparison
Curonest Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bashu Pharmaceuticals Private Limited | ₹38.26 Lakh (FY 2025) | 28.0% | Patna, Bihar, India | |||
| Emrick Pharmaceuticals Private Limited | ₹38.25 Lakh (FY 2025) | -18.0% | Bulandshahr, Uttar Pradesh, India | |||
| Arvensis Pharmaceuticals Private Limited | ₹38.11 Lakh (FY 2024) | -24.0% | Raipur, Chhattisgarh, India | |||
| Curonest Pharmaceuticals Private Limitedthis company | ₹38.1 Lakh (FY 2024) | ₹80,353 | 2.1% | -16.0% | Bangalore, Karnataka, India | |
| Katharine Pharmaceuticals Private Limited | ₹38.1 Lakh (FY 2025) | 45.0% | Jaipur, Rajasthan, India | |||
| Pentaproud Pharmaceuticals Private Limited | ₹37.93 Lakh (FY 2025) | -23.0% | Kochi, Kerala, India | |||
| Futurewell Pharmaceuticals Private Limited | ₹37.89 Lakh (FY 2024) | Kolkata, West Bengal, India | ||||
| Himcure Pharmaceuticals Private Limited | ₹37.86 Lakh (FY 2024) | 22.0% | Rampur, Uttar Pradesh, India |
To see the full peer comparison of Curonest Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Curonest Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curonest Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Curonest Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Curonest Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Manoranjan Kumar was appointed as Director on 18 Apr 2020.
Frequently asked questions
Curonest Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 18 April 2020 (6+ years old) and is registered under CIN U51909KA2020PTC133817.
Curonest Pharmaceuticals has 2 current directors:
- Rishi Ranjan - Director
- Manoranjan Kumar - Director
The latest financial statements of Curonest Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Curonest Pharmaceuticals is U51909KA2020PTC133817. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curonest Pharmaceuticals was incorporated on 18 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Curonest Pharmaceuticals by revenue are Bashu Pharmaceuticals Private Limited, Emrick Pharmaceuticals Private Limited, Arvensis Pharmaceuticals Private Limited, Katharine Pharmaceuticals Private Limited, Pentaproud Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manoranjan Kumar was appointed as Director on 18 Apr 2020. Rishi Ranjan was appointed as Director on 18 Apr 2020.
Yes, Curonest Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-20-0000572).
The registered office of Curonest Pharmaceuticals is at F – 301 N.D. Oliva #292A&293 Begur Hobli Haralakunte Village Somsunderpalaya Hs, R Layout 1, Bangalore, Karnataka, India – 560037.
Curonest Pharmaceuticals operates in the trading industry, in the specialty segment.
Curonest Pharmaceuticals can be reached at its registered office: F – 301 N.D. Oliva #292A&293 Begur Hobli Haralakunte Village Somsunderpalaya Hs, R Layout 1, Bangalore, Karnataka, India – 560037.

